Does Gender Play a Role in Bone-mineral Density Measurement Precision?
1 other identifier
observational
180
1 country
1
Brief Summary
Bone mineral density (BMD) measurement using dual-energy x-ray absorptiometry (DXA) is the current gold standard for osteoporosis diagnosis and therapy monitoring. Like all quantitative tests, there is some variability in BMD results obtained when scanning a person more than once. As such, it is current clinical practice, based on the recommendation of the International Society for Clinical Densitometry, that each technologist perform a precision assessment. This approach consists of scanning 30 people twice; the data from which allow determination of what constitutes a real difference in BMD with 95% confidence. A precision assessment typically evaluates a specific clinic's population, using the age range and genders seen at that clinic. However men generally have larger, but often more arthritic, bones than women which may impact the precision results. Therefore, it is possible that gender-specific precision values should be used in clinical practice, however this issue has never been investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 30, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedFirst Posted
Study publicly available on registry
March 29, 2011
CompletedOctober 5, 2015
March 1, 2011
6 months
September 30, 2010
October 1, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
DXA Bone Mineral Density precision
The primary analysis will compare DXA BMD precision (mean square error/variance) in males and females, pooled across technicians, using the two-sample F-test for equality of variances. Separate analyses will also be performed for each technician. In addition, due to the sensitivity of the F-test to the normality assumption, a secondary analysis will perform the same comparisons using Levene's test. A nominal two-sided p-value of 0.05 will be regarded as statistically significant.
1 day
Study Arms (2)
Males
Females
Eligibility Criteria
The study population will consist of 90 men and 90 women volunteers who are aged 65 years and older, able and willing to provide informed consent.
You may qualify if:
- Age ≥ 65 years
- Able and willing to sign informed consent
You may not qualify if:
- Inability to have DXA scans performed due to weight ≥ 450 pounds (exceeds densitometer table limit)
- Metallic hardware in, or overlaying, any of the measured skeletal sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin Osteoporosis Clinical Center and Research Program
Madison, Wisconsin, 53705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil Binkley, M.D.
University of Wisconsin, Madison
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2010
First Posted
March 29, 2011
Study Start
July 1, 2010
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
October 5, 2015
Record last verified: 2011-03